Oral N-acetylglucosamine for Crohn's disease
Part of Digestive system clinical trials.
This study tests an oral supplement called N-acetylglucosamine (a natural sugar) to see if it can help control Crohn's disease. It involves taking the supplement and attending follow-up visits, including some genetic testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- Your Crohn's disease must affect the last part of the small intestine (ileum) or both the ileum and colon.
- You need to be on a stable dose of your current Crohn's medication for at least 8 weeks.
- You must be willing to provide blood samples for genetic testing (ZIP8 gene).
- You cannot have taken steroids in the last 4 weeks or antibiotics in the last 2 weeks.
- You cannot have certain medical conditions like diabetes, heart disease, cancer, or chronic lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called SL-325, which may help reduce inflammation in the gut. It is for people with moderate to severe Crohn's disease who have not responded well to other treatments.
This trial tests a new, gentler way to diagnose Crohn's disease. If you have symptoms like long-lasting diarrhea or belly pain, this study may help find out if you have Crohn's without invasive procedures.
This study tests an oral medication called TAK-279 to see if it can safely reduce inflammation in the bowel for people with moderate to severe Crohn's disease who haven't had success with other treatments.
This study tests whether changing your diet and lifestyle can help repair the lining of your gut if you have Crohn's disease. It focuses on people whose Crohn's causes food-related symptoms or IBS-like symptoms, and involves a special scope procedure to check for food-triggered gut barrier damage.
This study looks at whether adding a special liquid nutrition supplement (called partial enteral nutrition) to a new Crohn's disease treatment can help control symptoms better than the treatment alone. It may help reduce inflammation and improve your quality of life.
This trial tests whether a glycan supplement can prevent Crohn's disease from coming back after surgery to remove the diseased part of the small and large intestine. It may help people who have had this specific surgery and are not taking certain other treatments.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.